TGA issues two new safety alerts for GLP-1 RA products
The Therapeutic Goods Administration (TGA) has today (Monday 1 December) made updates to product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two...
Supporting patients through GLP-1 agonist cessation effects
Glucagon-like peptide 1 (GLP-1) agonists, traditionally used to manage type 2 diabetes, have been increasingly prescribed off-label for weight loss.
There are four GLP-1 agonist...
Disposal of Schedule 8 medicines
Medicines, if disposed of unsafely, have the potential to both cause damage to the environment and pose a risk to public safety.
Think you know emergency contraception? Think again
Pharmacists have been supplying emergency contraception in Australia since 2004. Since then, the evidence base and consumer experience surrounding emergency contraception has evolved significantly.
Immediate-release melatonin for jet lag
The Therapeutic Goods Administration (TGA) has down- scheduled – to Schedule 3 Pharmacist Only – immediate-release melatonin preparations for the treatment of jet lag in adults aged 18 years or older.
Goodbye CAL I, hello expanded CAL 18
Merging CAL 18 and CAL I removes duplication and confusion, helping patients receive clearer, more actionable dietary advice.
